Unlike in non-cancerous cells, the level of JNK activation is considerably high in cancerous cells, such as cells of hepatocellular carcinomas (HCCs) and human pancreatic cancer cells, because JNK activity promotes tumor growth, proliferation, and survival61–63. Here, MAPK8 is linked to pancreatic neoplasm.